Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Lower Respiratory Tract Diseases Caused by Common Respiratory Viruses among Stem Cell Transplantation Recipients: A Single Center Experience in Korea.

Hong KW, Choi SM, Lee DG, Cho SY, Lee HJ, Choi JK, Kim SH, Park SH, Choi JH, Yoo JH, Lee JW.

Yonsei Med J. 2017 Mar;58(2):362-369. doi: 10.3349/ymj.2017.58.2.362.

2.

Clinical characteristics and factors associated with severe acute respiratory infection and influenza among children in Jingzhou, China.

Huai Y, Guan X, Liu S, Uyeki TM, Jiang H, Klena J, Huang J, Chen M, Peng Y, Yang H, Luo J, Zheng J, Peng Z, Huo X, Xiao L, Chen H, Zhang Y, Xing X, Feng L, Hu DJ, Yu H, Zhan F, Varma JK.

Influenza Other Respir Viruses. 2017 Mar;11(2):148-156. doi: 10.1111/irv.12419. Epub 2016 Sep 20.

3.

How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation.

Waghmare A, Englund JA, Boeckh M.

Blood. 2016 Jun 2;127(22):2682-92. doi: 10.1182/blood-2016-01-634873. Epub 2016 Mar 11.

PMID:
26968533
4.

Corticosteroids for severe influenza pneumonia: A critical appraisal.

Nedel WL, Nora DG, Salluh JI, Lisboa T, Póvoa P.

World J Crit Care Med. 2016 Feb 4;5(1):89-95. doi: 10.5492/wjccm.v5.i1.89. eCollection 2016 Feb 4. Review.

5.

Pandemic 2009 Influenza A (H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational study.

Dignani MC, Costantini P, Salgueira C, Jordán R, Guerrini G, Valledor A, Herrera F, Nenna A, Mora C, Roccia-Rossi I, Stecher D, Carbone E, Laborde A, Efron E, Altclas J, Calmaggi A, Cozzi J.

Version 2. F1000Res. 2014 Sep 12 [revised 2015 Aug 25];3:221. doi: 10.12688/f1000research.5251.2. eCollection 2014.

6.

Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management.

Hurt AC, Hui DS, Hay A, Hayden FG.

Influenza Other Respir Viruses. 2015 Jan;9(1):20-31. doi: 10.1111/irv.12293. Epub 2014 Nov 15. Review.

7.

Treatment of norovirus infections: moving antivirals from the bench to the bedside.

Kaufman SS, Green KY, Korba BE.

Antiviral Res. 2014 May;105:80-91. doi: 10.1016/j.antiviral.2014.02.012. Epub 2014 Feb 25. Review.

8.

Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets.

van der Vries E, Stittelaar KJ, van Amerongen G, Veldhuis Kroeze EJ, de Waal L, Fraaij PL, Meesters RJ, Luider TM, van der Nagel B, Koch B, Vulto AG, Schutten M, Osterhaus AD.

PLoS Pathog. 2013;9(5):e1003343. doi: 10.1371/journal.ppat.1003343. Epub 2013 May 23.

9.

Delayed opportunistic infections in hematopoietic stem cell transplantation patients: a surmountable challenge.

Marr KA.

Hematology Am Soc Hematol Educ Program. 2012;2012:265-70. doi: 10.1182/asheducation-2012.1.265. Review.

10.

Management of respiratory viral infections in hematopoietic cell transplant recipients.

Shah DP, Ghantoji SS, Mulanovich VE, Ariza-Heredia EJ, Chemaly RF.

Am J Blood Res. 2012;2(4):203-18. Epub 2012 Nov 25.

11.

Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients.

Renaud C, Campbell AP.

Curr Opin Infect Dis. 2011 Aug;24(4):333-43. doi: 10.1097/QCO.0b013e3283480440. Review.

12.

Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients.

Choi SM, Boudreault AA, Xie H, Englund JA, Corey L, Boeckh M.

Blood. 2011 May 12;117(19):5050-6. doi: 10.1182/blood-2010-11-319186. Epub 2011 Mar 3.

Supplemental Content

Support Center